Skip to main content

Want a detailed portfolio tracker?

Terns Pharmaceuticals (TERN) P/E (2021 - 2026)

Terns Pharmaceuticals (TERN) P/E from Mar 31, 2021 to May 5, 2026. The TTM Terns Pharmaceuticals (TERN) P/E is -50.88. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Terns Pharmaceuticals (TERN)

YearP/EChange
2026-50.88+31.06%
2025-38.82+725.47%
2024-4.70+5.03%
2023-4.48-7.40%
2022-4.84+36.26%
2021-3.55N/A

Comparison Terns Pharmaceuticals (TERN) P/E with competitors

Terns Pharmaceuticals (TERN) P/E is -50.88.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Therapeutics Ltd0.13-100.25%
FGENFibroGen Inc0.24-100.47%
TRAWTraws Pharma Inc0.47-100.93%
FBIOFortress Biotech Inc0.71-101.39%
CHRSCoherus Biosciences Inc0.80-101.57%
ORMPOramed Pharmaceuticals Inc1.37-102.69%
AGENAgenus Inc1.84-103.62%
VIVSVivoSim Labs Inc2.32-104.56%
INVAInnoviva Inc3.31-106.51%
CRMDCorMedix Inc3.78-107.43%
VXRTVaxart Inc3.95-107.77%
ABEOAbeona Therapeutics Inc3.96-107.78%
SRPTSarepta Therapeutics Inc4.19-108.23%
CVACCureVac N.V.4.45-108.74%
GLPGGalapagos NV4.86-109.55%
ABUSArbutus Biopharma Corp5.06-109.94%
RIGLRigel Pharmaceuticals5.16-110.14%
CGENCompugen Ltd5.24-110.30%
ZVRAZevra Therapeutics Inc6.13-112.05%
OMEROmeros Corporation9.11-117.90%
PLXProtalix BioTherapeutics Inc9.21-118.10%
SPROSpero Therapeutics Inc9.31-118.29%
AUPHAurinia Pharmaceuticals Inc9.32-118.32%
ACADAcadia Pharmaceuticals Inc9.62-118.90%
TBPHTheravance Biopharma Inc11.86-123.30%
ADMAAdma Biologics Inc12.13-123.84%
SABSSAB Biotherapeutics Inc12.93-125.40%
HRMYHarmony Biosciences Holdings Inc14.05-127.61%
REGNRegeneron Pharmaceuticals Inc14.36-128.22%
PBYIPuma Biotechnology Inc14.45-128.40%
INCYIncyte Corp14.49-128.47%
NAGENiagen Bioscience Inc14.82-129.12%
XOMAXOMA Corp14.95-129.38%
TGTXTG Therapeutics Inc15.67-130.80%
EXELExelixis Inc16.60-132.62%
CPRXCatalyst Pharmaceuticals Inc17.36-134.11%
MDXGMimedx Group Inc17.52-134.43%
CTMXCytomX Therapeutics Inc19.63-138.57%
ASNDAscendis Pharma A/S23.50-146.18%
HALOHalozyme Therapeutics Inc23.83-146.82%
ARGXArgen X SE24.24-147.64%
XOMAOXOMA Corp25.34-149.81%
VRTXVertex Pharmaceuticals Inc25.57-150.24%
XOMAPXOMA Corp25.67-150.45%
RPRXRoyalty Pharma plc - Class A27.78-154.58%
SLNOSoleno Therapeutics Inc29.02-157.02%
LGNDLigand Pharmaceuticals Inc - Class B31.77-162.43%
APLSApellis Pharmaceuticals Inc39.02-176.68%
BMRNBiomarin Pharmaceutical Inc40.22-179.04%
KRYSKrystal Biotech Inc40.45-179.48%
ONCBeiGene Ltd58.89-215.74%
PHARPharming Group N.V.68.77-235.16%
TECHBio-Techne Corp74.88-247.17%
VCELVericel Corp87.95-272.83%
GMABGenmab118.15-332.18%
ALNYAlnylam Pharmaceuticals Inc123.07-341.86%
TLXTelix Pharmaceuticals Ltd135.58-366.45%
CORTCorcept Therapeutics Inc185.65-464.84%